Evidence map›Paper›PMID 38597682›Full record

ArticleNucleic acids research2024

Somatic and intergenerational G4C2 hexanucleotide repeat instability in a human C9orf72 knock-in mouse model.

Nada Kojak, Junko Kuno, Kristina E Fittipaldi, Ambereen Khan, David Wenger, Michael Glasser, Roberto A Donnianni, Yajun Tang, Jade Zhang, Katie Huling and 19 more

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Emerging drivers of DNA repeat expansions.Biochemical Society transactions · 2025
    Review
  5. Recurrent DNA nicks drive massive expansions of (GAA)Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  6. Review
  7. NAR molecular medicine · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors at 1 institution in 1 country.

Nada KojakRegeneron Pharmaceuticals, Tarrytown, NY 10591, USA.
Junko KunoRegeneron Pharmaceuticals, Tarrytown, NY 10591, USA.
Kristina E FittipaldiRegeneron Pharmaceuticals, Tarrytown, NY 10591, USA.
Ambereen KhanRegeneron Pharmaceuticals, Tarrytown, NY 10591, USA.
David WengerRegeneron Pharmaceuticals, Tarrytown, NY 10591, USA.
Michael GlasserRegeneron Pharmaceuticals, Tarrytown, NY 10591, USA.
Roberto A DonnianniRegeneron Pharmaceuticals, Tarrytown, NY 10591, USA.
Yajun TangRegeneron Pharmaceuticals, Tarrytown, NY 10591, USA.
Jade ZhangRegeneron Pharmaceuticals, Tarrytown, NY 10591, USA.
Katie HulingRegeneron Pharmaceuticals, Tarrytown, NY 10591, USA.
Roxanne AllyRegeneron Pharmaceuticals, Tarrytown, NY 10591, USA.
Alejandro O MujicaRegeneron Pharmaceuticals, Tarrytown, NY 10591, USA.
Terrence TurnerRegeneron Pharmaceuticals, Tarrytown, NY 10591, USA.
Gina MagardinoRegeneron Pharmaceuticals, Tarrytown, NY 10591, USA.
Pei Yi HuangRegeneron Pharmaceuticals, Tarrytown, NY 10591, USA.
Sze Yen KerkRegeneron Pharmaceuticals, Tarrytown, NY 10591, USA.
Gustavo DroguettRegeneron Pharmaceuticals, Tarrytown, NY 10591, USA.
Marine PrissetteRegeneron Pharmaceuticals, Tarrytown, NY 10591, USA.
Jose RojasRegeneron Pharmaceuticals, Tarrytown, NY 10591, USA.
Teodoro GomezRegeneron Pharmaceuticals, Tarrytown, NY 10591, USA.
Anthony GagliardiRegeneron Pharmaceuticals, Tarrytown, NY 10591, USA.
Charleen HuntRegeneron Pharmaceuticals, Tarrytown, NY 10591, USA.
Jeremy S RabinowitzRegeneron Pharmaceuticals, Tarrytown, NY 10591, USA.
Guochun GongRegeneron Pharmaceuticals, Tarrytown, NY 10591, USA.
William PoueymirouRegeneron Pharmaceuticals, Tarrytown, NY 10591, USA.
Eric ChiaoRegeneron Pharmaceuticals, Tarrytown, NY 10591, USA.
Brian ZambrowiczRegeneron Pharmaceuticals, Tarrytown, NY 10591, USA.
Chia-Jen SiaoRegeneron Pharmaceuticals, Tarrytown, NY 10591, USA.
Daisuke KajimuraRegeneron Pharmaceuticals, Tarrytown, NY 10591, USA.ORCID 0009-0008-7399-0160
Regeneron (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Expansion of a G4C2 repeat in the C9orf72 gene is associated with familial Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). To investigate the underlying mechanisms of repeat instability, which occurs both somatically and intergenerationally, we created a novel mouse model of familial ALS/FTD that harbors 96 copies of G4C2 repeats at a humanized C9orf72 locus. In mouse embryonic stem cells, we observed two modes of repeat expansion. First, we noted minor increases in repeat length per expansion event, which was dependent on a mismatch repair pathway protein Msh2. Second, we found major increases in repeat length per event when a DNA double- or single-strand break (DSB/SSB) was artificially introduced proximal to the repeats, and which was dependent on the homology-directed repair (HDR) pathway. In mice, the first mode primarily drove somatic repeat expansion. Major changes in repeat length, including expansion, were observed when SSB was introduced in one-cell embryos, or intergenerationally without DSB/SSB introduction if G4C2 repeats exceeded 400 copies, although spontaneous HDR-mediated expansion has yet to be identified. These findings provide a novel strategy to model repeat expansion in a non-human genome and offer insights into the mechanism behind C9orf72 G4C2 repeat instability.

Indexed as

C9orf72 ProteinDNA Repeat ExpansionGenomic InstabilityAmyotrophic Lateral SclerosisAnimalsDisease Models, AnimalDNA Breaks, Double-StrandedFrontotemporal DementiaGene Knock-In TechniquesHumansMiceMutS Homolog 2 ProteinC9orf72 ProteinC9orf72 protein, humanMsh2 protein, mouseMutS Homolog 2 Protein

Identifiers

PMID38597682
PMCPMC11162798
OpenAlexW4394675048

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.